Search

everythinglearnresearchcommunity

for

Search:↓

A new gel improves hair loss treatment by effectively delivering minoxidil and finasteride to the scalp.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

A new compound effectively inhibits human 5α-reductase 1.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

CPGel hydrogel heals diabetic wounds effectively in 21 days.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

A woman with severe angioedema improved significantly after treatment with rituximab.

The new drug delivery system effectively targets lung cancer cells.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

The combination of encorafenib and binimetinib caused few skin issues.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Lokivetmab reduced itching in a dog with skin lymphoma.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Trilostane helped a cat with a hormone issue but the cat later died from a kidney infection.